BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

Mise à jour : Il y a 4 ans
Référence : NCT01034631

Femme et Homme

Extrait

The purpose of this study is to determine whether BNC105P in combination with/following everolimus is effective in the treatment of progressive metastatic clear cell renal cell carcinoma following prior tyrosine kinase inhibitors.


Critère d'inclusion

  • Renal Cell Carcinoma

Liens